FDA Drug Information Updates
reachmd.com
FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
2017年7月1日
Food and Drug Administration News
Food and Drug Administration Oversight
4:56:29
Food and Drug Administration Oversight
C-SPAN.org
已浏览 407 次2008年1月30日
Food Safety and the Food and Drug Administration | United States Senate Committee on Appropriations
Food Safety and the Food and Drug Administration | United States Senate Committee on Appropriations
senate.gov
2022年7月15日
Food and Drug Administration Oversight
2:13:40
Food and Drug Administration Oversight
C-SPAN.org
已浏览 146 次2007年5月5日
热门视频
FDA approves controversial Alzheimer's drug
2:18
FDA approves controversial Alzheimer's drug
CBS News
2021年6月7日
First new drug for Alzheimer's in 20 years approved by FDA
0:33
First new drug for Alzheimer's in 20 years approved by FDA
CBS News
2021年6月7日
FAERS Data: Three Ways the FDA Makes it Available to the Public
FAERS Data: Three Ways the FDA Makes it Available to the Public
reachmd.com
2017年7月3日
Food and Drug Administration FDA Approval Process
Washington Journal-FDA Drug Approval Process
25:31
Washington Journal-FDA Drug Approval Process
C-SPAN.org
已浏览 243 次2005年3月2日
FDA Approval Process Part 2
FDA Approval Process Part 2
C-SPAN.org
已浏览 86 次1996年5月2日
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. Consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that a new, unapproved drug is s
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. Consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that a new, unapproved drug is s
numerade.com
11 个月之前
反馈